But they also affect mast cells directly: Reduce mast cell degranulation , so fewer histamine releases Lower inflammation and regulate the immune system Support gut health , strengthening the gut lining and slowing digestion to improve food tolerance Protect the nervous system , reducing inflammation-related damage Even at low doses, GLP-1 medications can help calm multi-system reactions , including skin, gut, and brain symptoms
B12 deficiency prevention during GLP-1 therapy This is the more serious reason for B12 inclusion, and it is one that many patients are not informed about
Fasting triglyceride levels decreased by approximately 3035% at the 12mg retatrutide dose a magnitude that significantly exceeds what is seen with semaglutide or tirzepatide at their respective maximum doses
Specifically, the ELIXA (lixisenatide) trial studied patients with T2DM who had recent acute coronary syndrome and found that the addition of lixisenatide to conventional therapy did not result in a significant difference in cardiovascular endpoints relative to placebo (Table 1) [56]
